Alison L. O’Neil

Prof. Alison L. O’Neil

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Cell
Verified
Journal Article
Closed access
ECEric M. Christiansen
Eric M. Christiansen
SYSamuel J. Yang
Samuel J. Yang
DAD. Michael Ando
D. Michael Ando
AJAshkan Javaherian
Ashkan Javaherian
GSGaia Skibinski
Gaia Skibinski
SFSteven Finkbeiner
Steven Finkbeiner

28 June 2011 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
Alison L. O’NeilAlison L. O’Neil
Alison L. O’Neil
CRCourtney Reichhardt
Courtney Reichhardt
BJBenjamin Johnson
Benjamin Johnson
PPPeter E. Prevelige
Peter E. Prevelige
TDTrevor Douglas
Trevor Douglas

17 August 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MDMax Darnell
Max Darnell
Alison L. O’NeilAlison L. O’Neil
Alison L. O’Neil
AMAngelo Mao
Angelo Mao
LGLuo Gu
Luo Gu
LRLee L. Rubin
Lee L. Rubin
DMDavid J. Mooney
David J. Mooney
Significance: Cells have been shown to respond to a host of physical properties of the environments that surround them. However, given that these properties vary considerably across tissues, how these individual properties interact to form unique regulatory environments for cells is largely unknown. This work analyzes the transcriptional responses of cells to unique combinations of microenvironmental material properties to gain broad insights into the coupling among different properties, the magnitude of the transcriptional effects, and the role of cell type. We find significant coupling among these properties, large variation in the magnitude of the transcriptional changes, and qualitative differences in the responses based on cell type, demonstrating the significant context dependence of microenvironmental material sensing.

14 September 2010 in Biomacromolecules
Verified
Journal Article
Closed access
SKSebyung Kang
Sebyung Kang
MUMasaki Uchida
Masaki Uchida
Alison L. O’NeilAlison L. O’Neil
Alison L. O’Neil
RLRui Li
Rui Li
PPPeter E. Prevelige
Peter E. Prevelige
TDTrevor Douglas
Trevor Douglas

9 November 2012 in Biomacromolecules
Verified
Journal Article
Closed access
Alison L. O’NeilAlison L. O’Neil
Alison L. O’Neil
PPPeter E. Prevelige
Peter E. Prevelige
GBGautam Basu
Gautam Basu
TDTrevor Douglas
Trevor Douglas

3 August 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PAPrachi Anand
Prachi Anand
Alison L. O’NeilAlison L. O’Neil
Alison L. O’Neil
ELEmily Lin
Emily Lin
TDTrevor Douglas
Trevor Douglas
MHMandë Holford
Mandë Holford
The blood brain barrier (BBB) is often an insurmountable obstacle for a large number of candidate drugs, including peptides, antibiotics and chemotherapeutic agents. Devising an adroit delivery method to cross the BBB is essential to unlocking widespread application of peptide therapeutics. Presented here is an engineered nanocontainer for delivering peptidic drugs across the BBB encapsulating the analgesic marine snail peptide ziconotide (Prialt®). We developed a bi-functional viral nanocontainer based on theSalmonella typhimuriumbacteriophage P22 capsid, genetically incorporating ziconotide in the interior cavity and chemically attaching cell penetrating HIV-Tat peptide on the exterior of the capsid. Virus like particles (VLPs) of P22 containing ziconotide were successfully transported in several BBB models of rat and human brain microvascular endothelial cells (BMVEC) using a recyclable noncytotoxic endocytic pathway. This work demonstrates proof in principle for developing a possible alternative to intrathecal injection of ziconotide using a tunable VLP drug delivery nanocontainer to cross the BBB.